Analgesics
Antiandrogens
Antihistamines
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
 
next
study
previous
study
c19early.org COVID-19 treatment researchRemdesivirRemdesivir (more..)
Melatonin Meta
Metformin Meta
Antihistamines Meta
Azvudine Meta Molnupiravir Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis       

Single cell resolution of SARS-CoV-2 tropism, antiviral responses, and susceptibility to therapies in primary human airway epithelium

Fiege et al., PLOS Pathogens, doi:10.1371/journal.ppat.1009292
Jan 2021  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
In Vitro study using primary human airway epithelial cells showing heterogeneity in SARS-CoV-2 infection across cell types, with ciliated cells being the predominant cell target. Induction of interferon responses was rare and there was significant heterogeneity in antiviral gene signatures. Remdesivir treatment effectively inhibited viral replication across cell types and blunted hyperinflammatory responses. Heavily infected secretory cells expressed abundant IL-6, a potential mediator of COVID-19 pathogenesis.
Gérard, Zhou, Wu, Kamo, Choi, Kim show significantly increased risk of acute kidney injury with remdesivir.
Fiege et al., 28 Jan 2021, USA, peer-reviewed, 14 authors. Contact: shens@umn.edu, tbold@umn.edu, langlois@umn.edu.
In Vitro studies are an important part of preclinical research, however results may be very different in vivo.
This PaperRemdesivirAll
Single cell resolution of SARS-CoV-2 tropism, antiviral responses, and susceptibility to therapies in primary human airway epithelium
Jessica K Fiege, Joshua M Thiede, Hezkiel Arya Nanda, William E Matchett, Patrick J Moore, Noe Rico Montanari, Beth K Thielen, Jerry Daniel, Emma Stanley, Ryan C Hunter, Vineet D Menachery, Steven S Shen, Tyler D Bold, Ryan A Langlois
PLOS Pathogens, doi:10.1371/journal.ppat.1009292
The human airway epithelium is the initial site of SARS-CoV-2 infection. We used flow cytometry and single cell RNA-sequencing to understand how the heterogeneity of this diverse cell population contributes to elements of viral tropism and pathogenesis, antiviral immunity, and treatment response to remdesivir. We found that, while a variety of epithelial cell types are susceptible to infection, ciliated cells are the predominant cell target of SARS-CoV-2. The host protease TMPRSS2 was required for infection of these cells. Importantly, remdesivir treatment effectively inhibited viral replication across cell types, and blunted hyperinflammatory responses. Induction of interferon responses within infected cells was rare and there was significant heterogeneity in the antiviral gene signatures, varying with the burden of infection in each cell. We also found that heavily infected secretory cells expressed abundant IL-6, a potential mediator of COVID-19 pathogenesis.
Supporting information S1
References
Agostini, Andres, Sims, Graham, Sheahan et al., Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease, mBio, doi:10.1128/mBio.00221-18
Beigel, Tomashek, Dodd, Mehta, Zingman et al., Remdesivir for the Treatment of Covid-19-Final Report, N Engl J Med, doi:10.1056/NEJMoa2007764
Bonser, Koh, Johansson, Choksi, Cheng et al., Flow Cytometric Analysis and Purification of Airway Epithelial Cell Subsets, Am J Respir Cell Mol Biol, doi:10.1165/rcmb.2020-0149MA
Brann, Tsukahara, Weinreb, Lipovsek, Van Den Berge et al., Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia, Sci Adv, doi:10.1126/sciadv.abc5801
Brown, Won, Graham, Dinnon, Sims et al., Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase, Antiviral Res, doi:10.1016/j.antiviral.2019.104541
Busnadiego, Fernbach, Pohl, Karakus, Huber et al., Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2, mBio, doi:10.1128/mBio.01928-20
Butler, Hoffman, Smibert, Papalexi, Satija, Integrating single-cell transcriptomic data across different conditions, technologies, and species, Nature biotechnology, doi:10.1038/nbt.4096
Cao, Spielmann, Qiu, Huang, Ibrahim et al., The single-cell transcriptional landscape of mammalian organogenesis, Nature, doi:10.1038/s41586-019-0969-x
Chua, Lukassen, Trump, Hennig, Wendisch et al., COVID-19 severity correlates with airway epithelium-immune cell interactions identified by single-cell analysis, Nat Biotechnol, doi:10.1038/s41587-020-0602-4
De Jong, Van Sterkenburg, Hesseling, Kempenaar, Mulder et al., Ciliogenesis in human bronchial epithelial cells cultured at the air-liquid interface, Am J Respir Cell Mol Biol, doi:10.1165/ajrcmb.10.3.8117445
De Jong, Van Sterkenburg, Kempenaar, Dijkman, Ponec, Serial culturing of human bronchial epithelial cells derived from biopsies, Vitro Cell Dev Biol Anim, doi:10.1007/BF02633985
Dumm, Fiege, Waring, Kuo, Langlois et al., Non-lytic clearance of influenza B virus from infected cells preserves epithelial barrier function, Nature communications, doi:10.1038/s41467-019-08617-z
Fay, Aron, Macchietto, Markman, Esser-Nobis et al., Cell type-and replication stage-specific influenza virus responses in vivo, PLoS Pathog, doi:10.1371/journal.ppat.1008760
Haye, Burmakina, Moran, Garcı ´a-Sastre, Fernandez-Sesma, The NS1 protein of a human influenza virus inhibits type I interferon production and the induction of antiviral responses in primary human dendritic and respiratory epithelial cells, J Virol, doi:10.1128/JVI.02323-08
Hoffmann, Kleine-Weber, Schroeder, Kruger, Herrler et al., SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor, Cell, doi:10.1016/j.cell.2020.02.052
Hoffmann, Schroeder, Kleine-Weber, Mu ¨ller, Ma et al., Nafamostat Mesylate Blocks Activation of SARS-CoV-2: New Treatment Option for COVID-19, Antimicrob Agents Chemother, doi:10.1128/AAC.00754-20
Jia, Look, Shi, Hickey, Pewe et al., ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia, Journal of virology, doi:10.1128/JVI.79.23.14614-14621.2005
Kallfass, Lienenklaus, Weiss, Staeheli, Visualizing the beta interferon response in mice during infection with influenza A viruses expressing or lacking nonstructural protein 1, J Virol, doi:10.1128/JVI.00283-13
Killip, Jackson, Pe ´rez-Cidoncha, Fodor, Randall, Single-cell studies of IFN-β promoter activation by wild-type and NS1-defective influenza A viruses, J Gen Virol, doi:10.1099/jgv.0.000687
Kindler, Thiel, To sense or not to sense viral RNA-essentials of coronavirus innate immune evasion, Curr Opin Microbiol, doi:10.1016/j.mib.2014.05.005
Lokugamage, Hage, De Vries, Valero-Jimenez, Schindewolf et al., Type I interferon susceptibility distinguishes SARS-CoV-2 from SARS-CoV, J Virol, doi:10.1128/JVI.01410-20
Lucas, Wong, Klein, Castro, Silva et al., Longitudinal analyses reveal immunological misfiring in severe COVID-19, Nature, doi:10.1038/s41586-020-2588-y
Ma, Ng, Zappia, Gearing, Olshansky et al., Unique Transcriptional Architecture in Airway Epithelial Cells and Macrophages Shapes Distinct Responses following Influenza Virus Infection, J Virol, doi:10.1128/JVI.01986-18
Menachery, Eisfeld, Scha ¨fer, Josset, Sims et al., Pathogenic influenza viruses and coronaviruses utilize similar and contrasting approaches to control interferon-stimulated gene responses, mBio, doi:10.1128/mBio.01174-14
Milewska, Kula-Pacurar, Wadas, Suder, Szczepanski et al., Replication of Severe Acute Respiratory Syndrome Coronavirus 2 in Human Respiratory Epithelium, Journal of virology, doi:10.1128/JVI.00957-20
Monteagudo, Muñoz-Moreno, Fribourg, Potla, Mena et al., Differential Modulation of Innate Immune Responses in Human Primary Cells by Influenza A Viruses Carrying Human or Avian Nonstructural Protein 1, J Virol, doi:10.1128/JVI.00999-19
Okuda, Edwards, Martinez, Asakura, Dinnon, SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract, Cell, doi:10.1016/j.cell.2020.05.042
Plasschaert, Zilionis, Choo-Wing, Savova, Knehr et al., A single-cell atlas of the airway epithelium reveals the CFTR-rich pulmonary ionocyte, Nature, doi:10.1038/s41586-018-0394-6
Pruijssers, George, Scha ¨fer, Leist, Gralinksi et al., Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice, Cell Rep, doi:10.1016/j.celrep.2020.107940
Ravindra, Alfajaro, Gasque, Wei, Filler et al., Single-cell longitudinal analysis of SARS-CoV-2 infection in human bronchial epithelial cells, bioRxiv, doi:10.1101/2020.05.06.081695
Russell, Elshina, Kowalsky, Velthuis, Bloom, Single-Cell Virus Sequencing of Influenza Infections That Trigger Innate Immunity, Journal of virology, doi:10.1128/JVI.00500-19
Sheahan, Sims, Graham, Menachery, Gralinski et al., Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses, Sci Transl Med, doi:10.1126/scitranslmed.aal3653
Sheahan, Sims, Zhou, Graham, Pruijssers et al., An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice, Sci Transl Med, doi:10.1126/scitranslmed.abb5883
Sjaastad, Fay, Fiege, Macchietto, Stone et al., Distinct antiviral signatures revealed by the magnitude and round of virus replication in vivo, Proc Natl Acad Sci U S A, doi:10.1073/pnas.1807516115
Stifter, Bhattacharyya, Sawyer, Cootes, Stambas et al., Visualizing the Selectivity and Dynamics of Interferon Signaling In Vivo, Cell Rep, doi:10.1016/j.celrep.2019.11.021
Sungnak, Huang, Becavin, Berg, Queen et al., SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes, Nat Med, doi:10.1038/s41591-020-0868-6
Trapnell, Cacchiarelli, Grimsby, Pokharel, Li et al., The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells, Nat Biotechnol, doi:10.1038/nbt.2859
Vanderheiden, Ralfs, Chirkova, Upadhyay, Zimmerman et al., Type I and Type III Interferons Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures, J Virol, doi:10.1128/JVI.00985-20
Walls, Park, Tortorici, Wall, Mcguire et al., Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein, Cell, doi:10.1016/j.cell.2020.02.058
Wang, Cao, Zhang, Yang, Liu et al., Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro, Cell Res, doi:10.1038/s41422-020-0282-0
Xie, Muruato, Lokugamage, Narayanan, Zhang et al., An Infectious cDNA Clone of SARS-CoV-2, Cell host & microbe, doi:10.1016/j.chom.2020.04.004
Zhu, Wang, Liu, Liang, Ye et al., Morphogenesis and cytopathic effect of SARS-CoV-2 infection in human airway epithelial cells, Nat Commun, doi:10.1038/s41467-020-17796-z
Ziegler, Allon, Nyquist, Mbano, Miao et al., SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues, Cell, doi:10.1016/j.cell.2020.04.035
{ 'indexed': {'date-parts': [[2024, 6, 1]], 'date-time': '2024-06-01T05:09:27Z', 'timestamp': 1717218567404}, 'update-to': [ { 'updated': { 'date-parts': [[2021, 2, 9]], 'date-time': '2021-02-09T00:00:00Z', 'timestamp': 1612828800000}, 'DOI': '10.1371/journal.ppat.1009292', 'type': 'new_version', 'label': 'New version'}], 'reference-count': 43, 'publisher': 'Public Library of Science (PLoS)', 'issue': '1', 'license': [ { 'start': { 'date-parts': [[2021, 1, 28]], 'date-time': '2021-01-28T00:00:00Z', 'timestamp': 1611792000000}, 'content-version': 'vor', 'delay-in-days': 0, 'URL': 'http://creativecommons.org/licenses/by/4.0/'}], 'funder': [ { 'DOI': '10.13039/100000002', 'name': 'National Institutes of Health', 'doi-asserted-by': 'crossref', 'award': ['R01 AI148669']}, { 'DOI': '10.13039/100000002', 'name': 'National Institutes of Health', 'doi-asserted-by': 'publisher', 'award': ['R01 AI153602']}, { 'DOI': '10.13039/100000002', 'name': 'National Institutes of Health', 'doi-asserted-by': 'publisher', 'award': ['UL1TR002494']}, { 'DOI': '10.13039/100000002', 'name': 'National Institutes of Health', 'doi-asserted-by': 'publisher', 'award': ['T32 HL007741']}, { 'DOI': '10.13039/100000002', 'name': 'National Institutes of Health', 'doi-asserted-by': 'publisher', 'award': ['T32 AI055433']}], 'content-domain': {'domain': ['www.plospathogens.org'], 'crossmark-restriction': False}, 'abstract': '<jats:p>The human airway epithelium is the initial site of SARS-CoV-2 infection. We used flow ' 'cytometry and single cell RNA-sequencing to understand how the heterogeneity of this diverse ' 'cell population contributes to elements of viral tropism and pathogenesis, antiviral ' 'immunity, and treatment response to remdesivir. We found that, while a variety of epithelial ' 'cell types are susceptible to infection, ciliated cells are the predominant cell target of ' 'SARS-CoV-2. The host protease TMPRSS2 was required for infection of these cells. Importantly, ' 'remdesivir treatment effectively inhibited viral replication across cell types, and blunted ' 'hyperinflammatory responses. Induction of interferon responses within infected cells was rare ' 'and there was significant heterogeneity in the antiviral gene signatures, varying with the ' 'burden of infection in each cell. We also found that heavily infected secretory cells ' 'expressed abundant IL-6, a potential mediator of COVID-19 pathogenesis.</jats:p>', 'DOI': '10.1371/journal.ppat.1009292', 'type': 'journal-article', 'created': {'date-parts': [[2021, 1, 28]], 'date-time': '2021-01-28T19:47:56Z', 'timestamp': 1611863276000}, 'page': 'e1009292', 'update-policy': 'http://dx.doi.org/10.1371/journal.ppat.corrections_policy', 'source': 'Crossref', 'is-referenced-by-count': 78, 'title': 'Single cell resolution of SARS-CoV-2 tropism, antiviral responses, and susceptibility to ' 'therapies in primary human airway epithelium', 'prefix': '10.1371', 'volume': '17', 'author': [ { 'ORCID': 'http://orcid.org/0000-0002-4129-8742', 'authenticated-orcid': True, 'given': 'Jessica K.', 'family': 'Fiege', 'sequence': 'first', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0002-6603-281X', 'authenticated-orcid': True, 'given': 'Joshua M.', 'family': 'Thiede', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0003-1406-1659', 'authenticated-orcid': True, 'given': 'Hezkiel Arya', 'family': 'Nanda', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0001-7515-2226', 'authenticated-orcid': True, 'given': 'William E.', 'family': 'Matchett', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0003-1437-4831', 'authenticated-orcid': True, 'given': 'Patrick J.', 'family': 'Moore', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0002-2211-8881', 'authenticated-orcid': True, 'given': 'Noe Rico', 'family': 'Montanari', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0001-5922-0241', 'authenticated-orcid': True, 'given': 'Beth K.', 'family': 'Thielen', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0001-9462-177X', 'authenticated-orcid': True, 'given': 'Jerry', 'family': 'Daniel', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0003-1566-8559', 'authenticated-orcid': True, 'given': 'Emma', 'family': 'Stanley', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0003-3841-1676', 'authenticated-orcid': True, 'given': 'Ryan C.', 'family': 'Hunter', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0001-8803-7606', 'authenticated-orcid': True, 'given': 'Vineet D.', 'family': 'Menachery', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0001-7725-1260', 'authenticated-orcid': True, 'given': 'Steven S.', 'family': 'Shen', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0001-7360-6546', 'authenticated-orcid': True, 'given': 'Tyler D.', 'family': 'Bold', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0002-0515-571X', 'authenticated-orcid': True, 'given': 'Ryan A.', 'family': 'Langlois', 'sequence': 'additional', 'affiliation': []}], 'member': '340', 'published-online': {'date-parts': [[2021, 1, 28]]}, 'reference': [ { 'issue': '5', 'key': 'ppat.1009292.ref001', 'doi-asserted-by': 'crossref', 'first-page': '379', 'DOI': '10.1007/BF02633985', 'article-title': 'Serial culturing of human bronchial epithelial cells derived from ' 'biopsies', 'volume': '29A', 'author': 'PM de Jong', 'year': '1993', 'journal-title': 'In Vitro Cell Dev Biol Anim'}, { 'issue': '3', 'key': 'ppat.1009292.ref002', 'doi-asserted-by': 'crossref', 'first-page': '271', 'DOI': '10.1165/ajrcmb.10.3.8117445', 'article-title': 'Ciliogenesis in human bronchial epithelial cells cultured at the ' 'air-liquid interface', 'volume': '10', 'author': 'PM de Jong', 'year': '1994', 'journal-title': 'Am J Respir Cell Mol Biol'}, { 'issue': '5', 'key': 'ppat.1009292.ref003', 'doi-asserted-by': 'crossref', 'first-page': '681', 'DOI': '10.1038/s41591-020-0868-6', 'article-title': 'SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells ' 'together with innate immune genes', 'volume': '26', 'author': 'W Sungnak', 'year': '2020', 'journal-title': 'Nat Med'}, { 'issue': '23', 'key': 'ppat.1009292.ref004', 'doi-asserted-by': 'crossref', 'first-page': '14614', 'DOI': '10.1128/JVI.79.23.14614-14621.2005', 'article-title': 'ACE2 receptor expression and severe acute respiratory syndrome ' 'coronavirus infection depend on differentiation of human airway ' 'epithelia', 'volume': '79', 'author': 'HP Jia', 'year': '2005', 'journal-title': 'Journal of virology'}, { 'issue': '2', 'key': 'ppat.1009292.ref005', 'doi-asserted-by': 'crossref', 'first-page': '271', 'DOI': '10.1016/j.cell.2020.02.052', 'article-title': 'SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a ' 'Clinically Proven Protease Inhibitor', 'volume': '181', 'author': 'M Hoffmann', 'year': '2020', 'journal-title': 'Cell'}, { 'issue': '2', 'key': 'ppat.1009292.ref006', 'doi-asserted-by': 'crossref', 'first-page': '281', 'DOI': '10.1016/j.cell.2020.02.058', 'article-title': 'Structure, Function, and Antigenicity of the SARS-CoV-2 Spike ' 'Glycoprotein.', 'volume': '181', 'author': 'AC Walls', 'year': '2020', 'journal-title': 'Cell'}, { 'issue': '5', 'key': 'ppat.1009292.ref007', 'doi-asserted-by': 'crossref', 'first-page': '1016', 'DOI': '10.1016/j.cell.2020.04.035', 'article-title': 'SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human ' 'Airway Epithelial Cells and Is Detected in Specific Cell Subsets across ' 'Tissues', 'volume': '181', 'author': 'CGK Ziegler', 'year': '2020', 'journal-title': 'Cell'}, { 'issue': '1', 'key': 'ppat.1009292.ref008', 'doi-asserted-by': 'crossref', 'DOI': '10.1128/JVI.00999-19', 'article-title': 'Differential Modulation of Innate Immune Responses in Human Primary ' 'Cells by Influenza A Viruses Carrying Human or Avian Nonstructural ' 'Protein 1', 'volume': '94', 'author': 'PL Monteagudo', 'year': '2019', 'journal-title': 'J Virol'}, { 'issue': '13', 'key': 'ppat.1009292.ref009', 'doi-asserted-by': 'crossref', 'first-page': '6849', 'DOI': '10.1128/JVI.02323-08', 'article-title': 'The NS1 protein of a human influenza virus inhibits type I interferon ' 'production and the induction of antiviral responses in primary human ' 'dendritic and respiratory epithelial cells', 'volume': '83', 'author': 'K Haye', 'year': '2009', 'journal-title': 'J Virol'}, { 'issue': '3', 'key': 'ppat.1009292.ref010', 'doi-asserted-by': 'crossref', 'first-page': '107940', 'DOI': '10.1016/j.celrep.2020.107940', 'article-title': 'Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric ' 'SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice', 'volume': '32', 'author': 'AJ Pruijssers', 'year': '2020', 'journal-title': 'Cell Rep'}, { 'key': 'ppat.1009292.ref011', 'article-title': 'SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in ' 'the Respiratory Tract', 'author': 'YJ Hou', 'year': '2020', 'journal-title': 'Cell'}, { 'issue': '8', 'key': 'ppat.1009292.ref012', 'doi-asserted-by': 'crossref', 'first-page': '970', 'DOI': '10.1038/s41587-020-0602-4', 'article-title': 'COVID-19 severity correlates with airway epithelium-immune cell ' 'interactions identified by single-cell analysis', 'volume': '38', 'author': 'RL Chua', 'year': '2020', 'journal-title': 'Nat Biotechnol'}, { 'issue': '1', 'key': 'ppat.1009292.ref013', 'doi-asserted-by': 'crossref', 'first-page': '3910', 'DOI': '10.1038/s41467-020-17796-z', 'article-title': 'Morphogenesis and cytopathic effect of SARS-CoV-2 infection in human ' 'airway epithelial cells', 'volume': '11', 'author': 'N Zhu', 'year': '2020', 'journal-title': 'Nat Commun'}, { 'key': 'ppat.1009292.ref014', 'article-title': 'Single-cell longitudinal analysis of SARS-CoV-2 infection in human ' 'bronchial epithelial cells', 'author': 'NG Ravindra', 'year': '2020', 'journal-title': 'bioRxiv'}, { 'issue': '3', 'key': 'ppat.1009292.ref015', 'doi-asserted-by': 'crossref', 'first-page': '269', 'DOI': '10.1038/s41422-020-0282-0', 'article-title': 'Remdesivir and chloroquine effectively inhibit the recently emerged ' 'novel coronavirus (2019-nCoV) in vitro', 'volume': '30', 'author': 'M Wang', 'year': '2020', 'journal-title': 'Cell Res'}, { 'issue': '396', 'key': 'ppat.1009292.ref016', 'doi-asserted-by': 'crossref', 'DOI': '10.1126/scitranslmed.aal3653', 'article-title': 'Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic ' 'coronaviruses', 'volume': '9', 'author': 'TP Sheahan', 'year': '2017', 'journal-title': 'Sci Transl Med'}, { 'key': 'ppat.1009292.ref017', 'article-title': 'Remdesivir for the Treatment of Covid-19—Final Report', 'author': 'JH Beigel', 'year': '2020', 'journal-title': 'N Engl J Med'}, { 'issue': '541', 'key': 'ppat.1009292.ref018', 'doi-asserted-by': 'crossref', 'DOI': '10.1126/scitranslmed.abb5883', 'article-title': 'An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in ' 'human airway epithelial cell cultures and multiple coronaviruses in ' 'mice', 'volume': '12', 'author': 'TP Sheahan', 'year': '2020', 'journal-title': 'Sci Transl Med'}, { 'issue': '2', 'key': 'ppat.1009292.ref019', 'doi-asserted-by': 'crossref', 'DOI': '10.1128/mBio.00221-18', 'article-title': 'Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is ' 'Mediated by the Viral Polymerase and the Proofreading Exoribonuclease', 'volume': '9', 'author': 'ML Agostini', 'year': '2018', 'journal-title': 'mBio'}, { 'key': 'ppat.1009292.ref020', 'doi-asserted-by': 'crossref', 'first-page': '104541', 'DOI': '10.1016/j.antiviral.2019.104541', 'article-title': 'Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic ' 'deltacoronaviruses with a highly divergent RNA dependent RNA polymerase', 'volume': '169', 'author': 'AJ Brown', 'year': '2019', 'journal-title': 'Antiviral Res'}, { 'key': 'ppat.1009292.ref021', 'doi-asserted-by': 'crossref', 'first-page': '69', 'DOI': '10.1016/j.mib.2014.05.005', 'article-title': 'To sense or not to sense viral RNA—essentials of coronavirus innate ' 'immune evasion', 'volume': '20', 'author': 'E Kindler', 'year': '2014', 'journal-title': 'Curr Opin Microbiol'}, { 'issue': '3', 'key': 'ppat.1009292.ref022', 'doi-asserted-by': 'crossref', 'first-page': 'e01174', 'DOI': '10.1128/mBio.01174-14', 'article-title': 'Pathogenic influenza viruses and coronaviruses utilize similar and ' 'contrasting approaches to control interferon-stimulated gene responses', 'volume': '5', 'author': 'VD Menachery', 'year': '2014', 'journal-title': 'mBio'}, { 'issue': '11', 'key': 'ppat.1009292.ref023', 'doi-asserted-by': 'crossref', 'first-page': '3539', 'DOI': '10.1016/j.celrep.2019.11.021', 'article-title': 'Visualizing the Selectivity and Dynamics of Interferon Signaling In ' 'Vivo', 'volume': '29', 'author': 'SA Stifter', 'year': '2019', 'journal-title': 'Cell Rep'}, { 'issue': '3', 'key': 'ppat.1009292.ref024', 'doi-asserted-by': 'crossref', 'first-page': '357', 'DOI': '10.1099/jgv.0.000687', 'article-title': 'Single-cell studies of IFN-β promoter activation by wild-type and ' 'NS1-defective influenza A viruses', 'volume': '98', 'author': 'MJ Killip', 'year': '2017', 'journal-title': 'J Gen Virol'}, { 'issue': '12', 'key': 'ppat.1009292.ref025', 'doi-asserted-by': 'crossref', 'first-page': '6925', 'DOI': '10.1128/JVI.00283-13', 'article-title': 'Visualizing the beta interferon response in mice during infection with ' 'influenza A viruses expressing or lacking nonstructural protein 1', 'volume': '87', 'author': 'C Kallfass', 'year': '2013', 'journal-title': 'J Virol'}, { 'issue': '14', 'key': 'ppat.1009292.ref026', 'doi-asserted-by': 'crossref', 'DOI': '10.1128/JVI.00500-19', 'article-title': 'Single-Cell Virus Sequencing of Influenza Infections That Trigger ' 'Innate Immunity', 'volume': '93', 'author': 'AB Russell', 'year': '2019', 'journal-title': 'Journal of virology'}, { 'issue': '38', 'key': 'ppat.1009292.ref027', 'doi-asserted-by': 'crossref', 'first-page': '9610', 'DOI': '10.1073/pnas.1807516115', 'article-title': 'Distinct antiviral signatures revealed by the magnitude and round of ' 'influenza virus replication in vivo', 'volume': '115', 'author': 'LE Sjaastad', 'year': '2018', 'journal-title': 'Proc Natl Acad Sci U S A'}, { 'issue': '8', 'key': 'ppat.1009292.ref028', 'doi-asserted-by': 'crossref', 'first-page': 'e1008760', 'DOI': '10.1371/journal.ppat.1008760', 'article-title': 'Cell type- and replication stage-specific influenza virus responses in ' 'vivo', 'volume': '16', 'author': 'EJ Fay', 'journal-title': 'PLoS Pathog. 2020'}, { 'issue': '6', 'key': 'ppat.1009292.ref029', 'article-title': 'Unique Transcriptional Architecture in Airway Epithelial Cells and ' 'Macrophages Shapes Distinct Responses following Influenza Virus ' 'Infection', 'volume': '93', 'author': 'JZ Ma', 'year': '2019', 'journal-title': 'J Virol'}, { 'issue': '5', 'key': 'ppat.1009292.ref030', 'doi-asserted-by': 'crossref', 'first-page': '841', 'DOI': '10.1016/j.chom.2020.04.004', 'article-title': 'An Infectious cDNA Clone of SARS-CoV-2', 'volume': '27', 'author': 'X Xie', 'year': '2020', 'journal-title': 'Cell host & microbe'}, { 'key': 'ppat.1009292.ref031', 'article-title': 'Flow Cytometric Analysis and Purification of Airway Epithelial Cell ' 'Subsets', 'author': 'LR Bonser', 'year': '2020', 'journal-title': 'Am J Respir Cell Mol Biol'}, { 'issue': '15', 'key': 'ppat.1009292.ref032', 'doi-asserted-by': 'crossref', 'DOI': '10.1128/JVI.00957-20', 'article-title': 'Replication of Severe Acute Respiratory Syndrome Coronavirus 2 in Human ' 'Respiratory Epithelium', 'volume': '94', 'author': 'A Milewska', 'year': '2020', 'journal-title': 'Journal of virology'}, { 'issue': '19', 'key': 'ppat.1009292.ref033', 'doi-asserted-by': 'crossref', 'DOI': '10.1128/JVI.00985-20', 'article-title': 'Type I and Type III Interferons Restrict SARS-CoV-2 Infection of Human ' 'Airway Epithelial Cultures', 'volume': '94', 'author': 'A Vanderheiden', 'year': '2020', 'journal-title': 'J Virol'}, { 'key': 'ppat.1009292.ref034', 'article-title': 'Type I interferon susceptibility distinguishes SARS-CoV-2 from', 'author': 'KG Lokugamage', 'year': '2020', 'journal-title': 'SARS-CoV. J Virol'}, { 'issue': '5', 'key': 'ppat.1009292.ref035', 'doi-asserted-by': 'crossref', 'DOI': '10.1128/mBio.01928-20', 'article-title': 'Antiviral Activity of Type I, II, and III Interferons Counterbalances ' 'ACE2 Inducibility and Restricts SARS-CoV-2', 'volume': '11', 'author': 'I Busnadiego', 'year': '2020', 'journal-title': 'mBio'}, { 'issue': '4', 'key': 'ppat.1009292.ref036', 'doi-asserted-by': 'crossref', 'first-page': '381', 'DOI': '10.1038/nbt.2859', 'article-title': 'The dynamics and regulators of cell fate decisions are revealed by ' 'pseudotemporal ordering of single cells', 'volume': '32', 'author': 'C Trapnell', 'year': '2014', 'journal-title': 'Nat Biotechnol'}, { 'issue': '7745', 'key': 'ppat.1009292.ref037', 'doi-asserted-by': 'crossref', 'first-page': '496', 'DOI': '10.1038/s41586-019-0969-x', 'article-title': 'The single-cell transcriptional landscape of mammalian organogenesis', 'volume': '566', 'author': 'J Cao', 'year': '2019', 'journal-title': 'Nature'}, { 'issue': '1', 'key': 'ppat.1009292.ref038', 'doi-asserted-by': 'crossref', 'first-page': '779', 'DOI': '10.1038/s41467-019-08617-z', 'article-title': 'Non-lytic clearance of influenza B virus from infected cells preserves ' 'epithelial barrier function', 'volume': '10', 'author': 'RE Dumm', 'year': '2019', 'journal-title': 'Nature communications'}, { 'issue': '31', 'key': 'ppat.1009292.ref039', 'doi-asserted-by': 'crossref', 'DOI': '10.1126/sciadv.abc5801', 'article-title': 'Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory ' 'system suggests mechanisms underlying COVID-19-associated anosmia', 'volume': '6', 'author': 'DH Brann', 'year': '2020', 'journal-title': 'Sci Adv'}, { 'issue': '6', 'key': 'ppat.1009292.ref040', 'doi-asserted-by': 'crossref', 'DOI': '10.1128/AAC.00754-20', 'article-title': 'Nafamostat Mesylate Blocks Activation of SARS-CoV-2: New Treatment ' 'Option for COVID-19', 'volume': '64', 'author': 'M Hoffmann', 'year': '2020', 'journal-title': 'Antimicrob Agents Chemother'}, { 'key': 'ppat.1009292.ref041', 'article-title': 'Longitudinal analyses reveal immunological misfiring in severe COVID-19', 'author': 'C Lucas', 'year': '2020', 'journal-title': 'Nature'}, { 'issue': '5', 'key': 'ppat.1009292.ref042', 'doi-asserted-by': 'crossref', 'first-page': '411', 'DOI': '10.1038/nbt.4096', 'article-title': 'Integrating single-cell transcriptomic data across different ' 'conditions, technologies, and species', 'volume': '36', 'author': 'A Butler', 'year': '2018', 'journal-title': 'Nature biotechnology'}, { 'issue': '7718', 'key': 'ppat.1009292.ref043', 'doi-asserted-by': 'crossref', 'first-page': '377', 'DOI': '10.1038/s41586-018-0394-6', 'article-title': 'A single-cell atlas of the airway epithelium reveals the CFTR-rich ' 'pulmonary ionocyte', 'volume': '560', 'author': 'LW Plasschaert', 'year': '2018', 'journal-title': 'Nature'}], 'container-title': 'PLOS Pathogens', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://dx.plos.org/10.1371/journal.ppat.1009292', 'content-type': 'unspecified', 'content-version': 'vor', 'intended-application': 'similarity-checking'}], 'deposited': { 'date-parts': [[2021, 2, 10]], 'date-time': '2021-02-10T03:35:02Z', 'timestamp': 1612928102000}, 'score': 1, 'resource': {'primary': {'URL': 'https://dx.plos.org/10.1371/journal.ppat.1009292'}}, 'subtitle': [], 'editor': [{'given': 'Kanta', 'family': 'Subbarao', 'sequence': 'first', 'affiliation': []}], 'short-title': [], 'issued': {'date-parts': [[2021, 1, 28]]}, 'references-count': 43, 'journal-issue': {'issue': '1', 'published-online': {'date-parts': [[2021, 1, 28]]}}, 'URL': 'http://dx.doi.org/10.1371/journal.ppat.1009292', 'relation': { 'has-preprint': [ { 'id-type': 'doi', 'id': '10.1101/2020.10.19.343954', 'asserted-by': 'object'}]}, 'ISSN': ['1553-7374'], 'subject': [], 'container-title-short': 'PLoS Pathog', 'published': {'date-parts': [[2021, 1, 28]]}}
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit